News by Tag: Noninsulin Market
DPP-IV Inhibitors to Account for 17% of the Indian Oral Antidiabetics Market by 2015
July 1, 2011
Driven by a rich pipeline and a strong safety-efficacy profile, the market for DPP-IV inhibitors in India is expected to reach more than US$ 163 Million in the next five years.This would represent around 17% of total oral antidiabetics market by 2015
July 1, 2011
Driven by a rich pipeline and a strong safety-efficacy profile, the market for DPP-IV inhibitors in India is expected to reach more than US$ 163 Million in the next five years.This would represent around 17% of total oral antidiabetics market by 2015